Carbendazim

Research use only, not for human use.

Carbendazim is a broad-spectrum benzimidazole antifungal with potential antimitotic and antineoplastic activities.

Carbendazim is a broad-spectrum benzimidazole antifungal with potential antimitotic and antineoplastic activities.(In Vitro):Carbendazim (4-60 μM; 24 hours) has no effects on viability of HeLa cells in a CCK-8 assay.(In Vivo):Carbendazim (oral gavage; 100 and 500 mg/kg; once daily in diet; 28 days) induces hepatic lipid metabolism disorder, it results in a significant increase of hepatic lipid accumulation and triglyceride (TG) levels in mice.

——

Animal Model:6-week-old male ICR miceDosage:100 and 500 mg/kg Administration:Oral gavage; 100 and 500 mg/kg; once daily in diet; 28 days Result:Increased the relative mRNA levels of some key genes related to lipogenesis and TG synthesis.Up-regulated mRNA levels of IL-1b and IL-6 in the liver in mice.Increased the serum concentrations of 2 proinflammatory cytokines IL-1b and IL-6 at 500 mg/kg. However, in the fat tissues, onlyIL-1b in the CBZ-500-treated group increased significantly as compared with the control group.

Mercarzole | Carbendazole. Code name: FB462

Others

Other Targets

Others

——

——

10605-21-7

191.19

C9H9N3O2

>98% (HPLC)

DMSO: 10 mM

O=C(OC)NC1=NC2=CC=CC=C2N1

methyl 1H-benzo[d]imidazol-2-ylcarbamate

(-20℃)

With Ice Pack

≥ 2 years